Literature DB >> 24854044

[Medication adherence of 65 patients in hemodialysis in Togo].

K A Sabi1, B Noto-Kadou-Kaza1, Y E Amekoudi1, M C Tsevi1, F Sylla1, K Kossidze1, D A Gnionsahe2.   

Abstract

OBJECTIVE: The aim of this study was to assess adherence in people on hemodialysis and determine the factors of poor adherence.
MATERIAL AND METHODS: This cross-sectional study took place throughout the month of September, 2012, in the hemodialysis center of the Sylvanus Olympio University Hospital, the only such center in Togo.
RESULTS: The study included 65 patients, with a mean age of 49.5 years (range: 22 to 77 years), more often men (sex ratio: 1.82) and married (74 %). More than half (58%) had completed secondary education, while 73% belonged to the least advantaged socioeconomic class; 61 (94%) had health insurance, and 57% had been on dialysis for 1 to 4 years. The compliance rate was 11%. The main factors associated with good adherence were marital status (p = 0.0339) and the patient's general health status (p = 0.001). Treatment fatigue (p = 0.0347), forgetfulness (p = 0.0001), dosage forms and drug characteristics (p = 0.0198) were all factors of noncompliance. Therapeutic non-compliance was proportional to the number of drugs prescribed (p = 0.4263).
CONCLUSION: Adherence in hemodialysis patients in Togo is very poor.

Entities:  

Keywords:  Togo; drug compliance; hemodialysis

Mesh:

Year:  2014        PMID: 24854044     DOI: 10.1684/mst.2014.0320

Source DB:  PubMed          Journal:  Med Sante Trop        ISSN: 2261-3684


  2 in total

1.  [Depression in patients on chronic hemodialysis at the Sylvanus Olympio University Hospital of Lomé (Togo)].

Authors:  Mawufemo Yawovi Tsevi; Saliou Salifou; Akomola Kossi Sabi; Befa Noto-Kadou-Kaza; Eyram Yoan Amekoudi; Simliwa Kolou Dassa
Journal:  Pan Afr Med J       Date:  2016-09-27

2.  Treatment adherence and perception in patients on maintenance hemodialysis: a cross - sectional study from Palestine.

Authors:  Karam Sh Naalweh; Mohammad A Barakat; Moutaz W Sweileh; Samah W Al-Jabi; Waleed M Sweileh; Sa'ed H Zyoud
Journal:  BMC Nephrol       Date:  2017-05-30       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.